文献速递颅颌面外科

中面部前徙联合正颌手术治疗中面部发育不全与错颌畸形

Simultaneous Midface Advancement and Orthognathic Surgery: A Powerful Technique for Managing Midface Hypoplasia and Malocclusion.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

3例(12%)发生需再次正颌手术的主要并发症,结论认为该技术相对安全,适用于特定全中面部后缩合并III类错颌患者。

要点

  • Le Fort III/I同期前徙可用于全中面部后缩合并III类错颌的特定患者。
  • Le Fort III平均前徙6.18±1.38 mm,Le Fort I平均6.70±2.48 mm。
  • 主要并发症12%,需再次正颌手术;轻微并发症40%。

核心结论

  • 作者经验再次证实Le Fort III/I同期前徙相对安全,应考虑用于特定全中面部后缩合并III类错颌患者。

主要发现

  • Le Fort III前徙平均6.18±1.38 mm,Le Fort I前徙平均6.70±2.48 mm。
  • 平均随访1.3±1.0年,1例术中脑脊液漏经期待处理缓解。
  • 3例(12%)术后发生需再次正颌手术的主要并发症,10例(40%)发生轻微并发症。
  • 平均住院10天,所有患者面部轮廓均获改善。

临床怎么用

  • 对特定全中面部后缩合并III类错颌患者,可考虑Le Fort III/I同期前徙以改善面部轮廓。
  • 需警惕术后主要并发症(12%)可能需再次正颌手术,并关注脑脊液漏等术中风险。

局限性

  • 回顾性研究,证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Midface hypoplasia dramatically affects the normative facial cascade. Simultaneous Le Fort III and Le Fort I procedures (Le Fort III/I) provide a powerful tool for achieving significant midface advancement. This study presents the authors' approach for addressing midface hypoplasia in the setting of class III malocclusion using Le Fort III/I advancement. METHODS: This was an institutional review board-approved retrospective review of patients who underwent Le Fort III/I advancement at the authors' institution from 2009 to 2019. Demographic, surgical, and postoperative data were recorded. The authors' operative technique and surgical pearls are described. RESULTS: Twenty-five patients met inclusion criteria, 15 male patients (60 percent) and 10 female patients (40 percent). Patient age ranged from 14.9 to 21.6 years. Diagnoses included Crouzon syndrome, nonsyndromic developmental skeletal dysplasia, cleft lip/palate, Klippel-Feil syndrome, Apert syndrome, Van den Ende-Gupta syndrome, and Pfeiffer syndrome. Le Fort III advancements averaged 6.18 ± 1.38 mm and Le Fort I advancements averaged 6.70 ± 2.48 mm. Thirteen patients underwent simultaneous bilateral sagittal split osteotomy with average movement of 5.85 ± 1.21 mm. Average follow-up was 1.3 ± 1.0 years. One patient experienced intraoperative cerebrospinal fluid leak that resolved with expectant management. Three patients experienced major complications (12 percent) postoperatively necessitating repeated orthognathic operations. Ten patients experienced minor complications (40 percent). Average length of stay was 10 days, with all patients achieving improvement of their facial profile. CONCLUSIONS: The authors' experience reaffirms the relative safety of simultaneous Le Fort III/I advancement. This technique should be considered in select patients with global midface retrusion and class III malocclusion. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hammoudeh JA, Goel P, Wolfswinkel EM, et al. Simultaneous Midface Advancement and Orthognathic Surgery: A Powerful Technique for Managing Midface Hypoplasia and Malocclusion. Plast Reconstr Surg. 2020. PMID: 32459778. doi:10.1097/PRS.0000000000006816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。